QbD Based Formulation Development of Delayed-Release Beads for Better Management of Nocturnal Asthma

The present study discusses about the quality by design (QbD) based formulation development and characterization of delayed release beads for better management of Nocturnal Asthma. Ionotropic gelation technique was used to create Budisonide-loaded pectin-alginate beads, and calcium chloride was added as a crosslinking agent. The central composite design model was used to optimize the beads. The response of beads was 91.9861 % for loading efficiency, 0.998 mm for bead size, and 360 min for time required for 90% drug release. The optimal formulation variables for a formulation were found to be 4.14 mg of pectin, 1.82 mg of alginate, 14.36% of CaCl2, and 5.99 hours of cross-linking time. PEC-ALG beads showed no release in 0.1 N HCl (pH 1.2). In contrast, increased Ca2+ and Na+ ion exchange as well as solvent penetration into the pectin-alginate network have been linked to the quick release from cross-linked beads in phosphate buffer pH 7.4. FTIR results showed that there was no interaction between the medication and the polymers, as evidenced by the significant peaks of BUD detected in the beads. An in vitro study of the toxicity of beads on A549 cell lines revealed significantly higher cell viability than the group of cells treated with pure BUD.BUD loaded PEC-ALG beads could have potential for chrono modulated delivery system for targeting nocturnal asthma.